Skip to main content
. Author manuscript; available in PMC: 2010 Nov 30.
Published in final edited form as: Nephron. 1987;46(Suppl 1):19–33. doi: 10.1159/000184431

Fig. 7.

Fig. 7

Response of serum bilirubin (TBIL) and serum glutamic oxaloacetic transaminase (SGOT) in the patients of group 2, whose rejection was diagnosed between 10 days and 3 months after liver replacement. The crosses indicate the loss of the graft, and the asterisk is on the curve of a patient who developed herpes virus hepatitis after OKT3 therapy.